Clinical Trial Update: Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC [Phase 2]

View source ↗

Summary

Phase 2 trial comparing flat-dose versus weight-based intraperitoneal chemotherapy for CRS/HIPEC in peritoneal carcinomatosis; the study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Carcinomatosis

Snippet

Sponsor: Prakash Pandalai | Conditions: Peritoneal Carcinomatosis | Phase 2 | Status: RECRUITING